Search results for "Base"

showing 10 items of 8362 documents

Oral hygiene instructions and professional control as part of the treatment of desquamative gingivitis. Systematic review

2019

Background The aim of this present article was to evaluate the scientific evidence on the efficacy of daily hygiene and professional prophylaxis for treatment of desquamative gingivitis. Material and Methods The present systematic review was conducted following the PRISMA protocol. Searches were carried out in Pubmed, Embase, Web of Science and Cochrane Library up to July 2018, randomized clinical trials and cohort studies on desquamative gingivitis (DG), and oral diseases joined to DG. Results After screening, we found that nine publications met the eligibility criteria eight cohort studies and one randomized control trial. The diagnosis of the diseases corresponded to oral lichen planus (…

medicine.medical_specialtyPemphigoidDatabases FactualBiopsyPemphigoid Benign Mucous MembraneDental PlaqueReviewCochrane LibraryOral hygienelaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawInternal medicinemedicineHumansGeneral DentistryOral Medicine and Pathologyintegumentary systembusiness.industryDental Plaque IndexDental Prophylaxis030206 dentistryOral Hygiene:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseGingivitisDental PolishingDesquamative gingivitisstomatognathic diseasesOtorhinolaryngologyMeta-analysisUNESCO::CIENCIAS MÉDICASDental ScalingSurgeryOral lichen planusPeriodontal IndexbusinessPemphigusLichen Planus OralCohort study
researchProduct

Twelve-Week Internet-Based Individualized Exercise Program in Adults With Systemic Lupus Erythematosus: Protocol for a Randomized Controlled Trial

2020

Background Systemic lupus erythematosus is a systemic autoimmune disease, which is associated with high cardiovascular risk, a predisposition to metabolic disorders, muscle wasting, and fatigue. Exercise therapy has become an important part of the long-term treatment of comorbidities in systemic lupus erythematosus. Exercise can lead to various benefits in patients with systemic lupus erythematosus such as increased aerobic capacity and exercise tolerance, resulting in an increased quality of life, decreased depression, and decreased fatigue. At the moment, no evidence-based treatment guidelines that recommend exercise for patients with systemic lupus erythematosus exist. Also, the efficac…

medicine.medical_specialtyPhysical fitnessComputer applications to medicine. Medical informaticsR858-859.7physical activitylaw.invention03 medical and health sciences0302 clinical medicinesystemic lupus erythematosusQuality of lifeRandomized controlled triallawinternet-based exercise program disease activityInternal medicineProtocolmedicineAerobic exerciseOutpatient clinic030212 general & internal medicineWasting030203 arthritis & rheumatologybusiness.industryRGeneral MedicineRheumatologyMedicinefatiguemedicine.symptombusinessAnaerobic exerciseJMIR Research Protocols
researchProduct

Feasibility of future epidemiological studies on possible health effects of mobile phone base stations.

2006

The increasing deployment of mobile communication base stations led to an increasing demand for epidemiological studies on possible health effects of radio frequency emissions. The methodological challenges of such studies have been critically evaluated by a panel of scientists in the fields of radiofrequency engineering/dosimetry and epidemiology. Strengths and weaknesses of previous studies have been identified. Dosimetric concepts and crucial aspects in exposure assessment were evaluated in terms of epidemiological studies on different types of outcomes. We conclude that in principle base station epidemiological studies are feasible. However, the exposure contributions from all relevant …

medicine.medical_specialtyPhysiologybusiness.industryRadio WavesPublic healthBiophysicsGeneral MedicineEnvironmental exposureEnvironmental ExposureSensitivity and SpecificityBase stationMobile phoneEnvironmental healthEpidemiologic Research DesignEpidemiologyMedicineHumansRadiology Nuclear Medicine and imagingMobile telephonyPublic HealthbusinessMicrowavesStrengths and weaknessesCell PhoneExposure assessmentBioelectromagnetics
researchProduct

Experiences of a poison center with metformin-associated lactic acidosis.

2004

Metformin is widely used in the treatment of type 2 diabetes, though it is recognized to be associated with the risk of lactic acidosis. A case of pronounced lactic acidosis with cardiac arrest (pH 6.60, lactate 17.5 mmol/l, base excess - 30, standard bicarbonate 2.5 mmol/l, core body temperature 27.8 degrees C) is presented in a 61-year-old woman under metformin therapy. The key laboratory abnormalities observed during the intensive care treatment including repeated hemodialysis are described. The patient showed a complete recovery with residually reduced mental capabilities. Furthermore, an explorative data analysis of our poison center database from 1995 until 2003 concerning metformin w…

medicine.medical_specialtyPoison Control Centersendocrine system diseasesEndocrinology Diabetes and MetabolismPoison controlSuicide AttemptedType 2 diabetesGastroenterologyEndocrinologyInternal medicineInternal MedicinemedicineHumansHypoglycemic AgentsAcidosisbusiness.industryMetabolic disordernutritional and metabolic diseasesMetabolic acidosisGeneral MedicineMiddle Agedmedicine.diseaseMetforminSurgeryMetforminDiabetes Mellitus Type 2Lactic acidosisBase excessAcidosis LacticFemalemedicine.symptombusinessmedicine.drugExperimental and clinical endocrinologydiabetes : official journal, German Society of Endocrinology [and] German Diabetes Association
researchProduct

Prevention of venous thromboembolic events occurring in myeloma patients treated with second-generation novel agents

2021

Thrombosis and neoplasms are strictly linked, and the diagnosis of a malignancy is a relevant risk factor for venous thromboembolism (VTE). In particular, between gammopathies, the VTE risk is known to be increased in both monoclonal gammopathy of uncertain significance and in multiple myeloma, with a 3- and 9-fold increase respectively, when compared to the general population. The risk appears to be further increased in patients treated with immunomodulating drugs, such as thalidomide, especially when in combination with dexamethasone or conventional cytotoxic chemotherapies, and lenalidomide. In 2008 the International Myeloma Working Group put out thrombosis prophylaxis recommendations fo…

medicine.medical_specialtyPopulationAntineoplastic Agents030204 cardiovascular system & hematologyRisk Assessment03 medical and health sciencesAntineoplastic Agents Immunological0302 clinical medicineFibrinolytic AgentsRisk FactorsInternal medicinemedicineHumansImmunologic FactorsRisk factoreducationMultiple myelomaLenalidomideeducation.field_of_study030219 obstetrics & reproductive medicinebusiness.industryWarfarinAnticoagulantsVenous ThromboembolismGeneral MedicineEvidence-based medicinemedicine.diseaseThrombosisPrevention and controlThalidomideTreatment OutcomeMultiple MyelomabusinessProteasome Inhibitorsmedicine.drugPanminerva Medica
researchProduct

Cigarette Smoking Is Related to Endothelial Dysfunction of Resistance, but Not Conduit Arteries in the General Population—Results From the Gutenberg …

2021

Aims: Cigarette smoking is one of the most complex and least understood cardiovascular risk factors. Importantly, differences in the tobacco-related pathophysiology of endothelial dysfunction, an early event in atherogenesis, between circulatory beds remain elusive. Therefore, this study evaluated how smoking impacts endothelial function of conduit and resistance arteries in a large population-based cohort.Methods and results: 15,010 participants (aged 35–74 years) of the Gutenberg Health Study were examined at baseline from 2007 to 2012. Smoking status, pack-years of smoking, and years since quitting smoking were assessed by a computer-assisted interview. Endothelial function of conduit an…

medicine.medical_specialtyPopulationCardiovascular Medicine030204 cardiovascular system & hematologysmoking03 medical and health sciences0302 clinical medicinemedicine.arteryInternal medicinemedicineDiseases of the circulatory (Cardiovascular) systemendothelial (dys)functionflow-mediated dilation030212 general & internal medicineBrachial arteryEndothelial dysfunctioneducationReactive hyperemiaOriginal Researcheducation.field_of_studybusiness.industryConfoundingmedicine.diseaseFormer Smokerpopulation-basedperipheral arterial tonometryRC666-701CohortCirculatory systemCardiologyCardiology and Cardiovascular MedicinebusinessFrontiers in Cardiovascular Medicine
researchProduct

Prevention of intrauterine post-surgical adhesions in hysteroscopy. A systematic review

2016

Abstract Objective The purpose of the present review is to provide a survey of the various measures of preventing adhesions used in hysteroscopic surgery. Study Design A systematic computerized literature search was conducted to provide a survey of the various measures used in hysteroscopic surgery to prevent adhesions. Finally, 29 studies were included in the analysis, showing a wide variety of methods and agents advocated in international literature. They are explained in various sections, based on the IUA prevention approach adopted (surgical technique, early second-look hysteroscopy, barrier method, pharmacological therapy). Results The results of our review show that (i) use of surgica…

medicine.medical_specialtyPost surgicalElectrosurgerymedicine.medical_treatmentReproductive medicineTissue AdhesionsPrevention approachHysteroscopylaw.invention03 medical and health sciencesPostoperative Complications0302 clinical medicineObstetrics and gynaecologyRandomized controlled triallawmedicineHumansIntrauterine adhesionIntensive care medicineEvidence-Based Medicine030219 obstetrics & reproductive medicinemedicine.diagnostic_testbusiness.industryPreventionMedicine (all)Hysteroscopy Intrauterine adhesion Prevention Medicine (all) Reproductive Medicine Obstetrics and GynecologyUterusObstetrics and GynecologyEvidence-based medicineSurgeryReproductive MedicineHysteroscopy030220 oncology & carcinogenesisFemalebusiness
researchProduct

Similar cardiovascular outcomes in patients with diabetes and established or high risk for coronary vascular disease treated with dulaglutide with an…

2020

Digital

medicine.medical_specialtyProportional hazards modelbusiness.industryHazard ratioType 2 diabetes030204 cardiovascular system & hematologyCardiovascular diseasemedicine.diseasePlaceboMetforminMetformin03 medical and health sciences0302 clinical medicineDiabetes mellitusInternal medicineGLP-1-based therapymedicineDulaglutide030212 general & internal medicinePrediabetesMortalityMorbidityCardiology and Cardiovascular Medicinebusinessmedicine.drugEuropean Heart Journal
researchProduct

Pharmacogenetics in Neuroblastoma: What Can Already Be Clinically Implemented and What Is Coming Next?

2021

Pharmacogenetics is one of the cornerstones of Personalized Precision Medicine that needs to be implemented in the routine of our patients’ clinical management in order to tailor their therapies as much as possible, with the aim of maximizing efficacy and minimizing toxicity. This is of great importance, especially in pediatric cancer and even more in complex malignancies such as neuroblastoma, where the rates of therapeutic success are still below those of many other types of tumors. The studies are mainly focused on germline genetic variants and in the present review, state of the art is presented: which are the variants that have a level of evidence high enough to be implemented in the c…

medicine.medical_specialtyQH301-705.5Antineoplastic AgentsReviewchemotherapyPediatricsCatalysisInorganic ChemistryNeuroblastomadrug labelQuimioteràpiamedicineHumansMedical physicsBiology (General)Precision MedicinePhysical and Theoretical Chemistryclinical implementation guidelinesQD1-999SNP (single nucleotide polymorphism)Molecular BiologySpectroscopybusiness.industryOrganic ChemistryGenetic variantsGeneral MedicineEvidence-based medicinePrecision medicinePediatric cancerComputer Science ApplicationsChemistryPharmacogeneticsFarmacogenèticabusinessPharmacogenetics
researchProduct

Cross-reactivity of anti-ssDNA antibodies with heparan sulfate in patients with type I diabetes mellitus

1989

Anti-single-stranded–DNA antibodies cross-reactive with heparan sulfate were detected in serums of patients with type I (insulin-dependent) diabetes mellitus. The results suggested that heparan sulfate, the major glycosaminoglycan constituent of the glomerular basement membrane, may serve as a target antigen in vivo for cross-reactive anti-DNA antibodies. These polyreactive antibodies, directed toward repeating negatively charged units, may neutralize the heparan sulfate–associated polyanionic sites in the glomerulus, leading to an abnormal permeability of anionic plasma proteins.

medicine.medical_specialtyRenal glomerulusEndocrinology Diabetes and MetabolismDNA Single-StrandedEnzyme-Linked Immunosorbent AssayPerlecanCross ReactionsBiologyGlycosaminoglycanchemistry.chemical_compoundInternal medicinemedicineInternal MedicineHumansChildGlycosaminoglycansBasement membraneGlomerular basement membraneHeparan sulfateBlood proteinsMolecular biologyDiabetes Mellitus Type 1Endocrinologymedicine.anatomical_structurechemistryImmunoglobulin Gbiology.proteinHeparitin SulfateAntibody
researchProduct